NGLFINEPharmaceuticals

NGL Fine Chem LtdQuarterly Results & Earnings

2057.10
-5.32%
Profit Growth YoY-1.83%Latest quarter
Sales Growth YoY28.65%Latest quarter
Sales CAGR 5Y19.41%5 year compound
Profit CAGR 5Y16.89%5 year compound
📋

Quarterly Performance

YoY Profit Growth-1.83%
⚠️ Mild contraction
YoY Sales Growth+28.65%
🔥 Exceptional growth
OPM 5Y Average
Operating profit margin
17.42%
EPS Growth 5Y
16.89%
Interest Coverage
Higher = safer debt servicing
7.87
ROE
7.75%
ROCE
9.44%
💡

Growth Analysis

NGL Fine Chem Ltd reported YoY profit growth of -1.83% and revenue growth of 28.65% in the latest quarter. Mild profit contraction — investigate if one-time or structural. Over 5 years, sales compounded at 19.41% and profits at 16.89% annually. This is above-average growth for Indian listed companies. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.